palladium has been researched along with Alzheimer Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 7 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Guo, X; Jia, Z; Li, J; Liu, J; Wei, JA; Yuan, X; Zhang, L; Zhou, H | 1 |
| Abid, A; Eijaz, S; Lateef, M; Rafiq, N; Tauseef, S | 1 |
| Choquesillo-Lazarte, D; Fernández-Bolaños, JG; García-García, A; López, Ó; Navarro-Hortal, MD; Quiles, JL; Rivas-García, L; Rodríguez-Diéguez, A; Rojas, S; Romero-Márquez, JM; Salinas-Castillo, A | 1 |
| Gao, F; Ji, WS; Lei, Y; Shan, LH; Wan, LX; Xiao, Y; Xu, JB; Zhang, Y; Zhou, XL | 1 |
| Gao, F; Miao, SX; Wan, LX; Xu, JB | 1 |
| Agrawal, S; Chauhan, R; Ghosh, K; Navale, GR; Saini, R; Sarkar, D; Sarma, M; Singh, HK; Singh, S | 1 |
| Gao, F; He, ZX; Li, X; Miao, SX; Wan, LX; Zhou, XL | 1 |
| Bartels, B; Cueni, P; Koerner, M; Muri, D | 1 |
| Du, X; He, Q; Jin, Z; Liu, Q; Yue, C; Zhang, L; Zhao, P | 1 |
| Chen, L; Gong, Y; Liu, J; Liu, Y; Yin, T; Yuan, G; Zhou, H | 1 |
| Bang-Andersen, B; Lindhardt, AT; Neumann, KT; Skrydstrup, T | 1 |
| Itami, K; Kirchberg, S; Studer, A; Tani, S; Ueda, K; Yamaguchi, J | 1 |
| Buchwald, SL; Hennessy, EJ | 1 |
13 other study(ies) available for palladium and Alzheimer Disease
| Article | Year |
|---|---|
A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Free Radical Scavengers; Humans; Materials Testing; Membrane Potential, Mitochondrial; Mice; Mitochondria; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Palladium | 2021 |
Multi-activity tetracoordinated pallado-oxadiazole thiones as anti-inflammatory, anti-Alzheimer, and anti-microbial agents: Structure, stability and bioactivity comparison with pallado-hydrazides.
Topics: Alzheimer Disease; Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Cholinesterase Inhibitors; Fungi; Hydrazines; Lipoxygenase Inhibitors; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Palladium; Structure-Activity Relationship; Thiones | 2022 |
A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Caenorhabditis elegans; Coordination Complexes; Disease Models, Animal; Gliclazide; Molecular Conformation; Palladium; Protective Agents | 2022 |
Palladium-Catalyzed Synthesis, Acetylcholinesterase Inhibition, and Neuroprotective Activities of
Topics: Acetylcholinesterase; Alzheimer Disease; Catalysis; Cholinesterase Inhibitors; Galantamine; Humans; Hydrogen Peroxide; Molecular Docking Simulation; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Palladium; Structure-Activity Relationship | 2023 |
Palladium-catalyzed synthesis and acetylcholinesterase inhibitory activity evaluation of 1-arylhuperzine A derivatives.
Topics: Acetylcholinesterase; Alzheimer Disease; Catalysis; Cholinesterase Inhibitors; Palladium | 2023 |
Inhibition of amyloid β
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Circular Dichroism; Humans; Molecular Docking Simulation; Palladium; Peptide Fragments; Programmed Cell Death 1 Receptor | 2023 |
Pd-Catalyzed Direct Diversification of Natural Anti-Alzheimer's Disease Drug: Synthesis and Biological Evaluation of
Topics: Alkaloids; Alzheimer Disease; Blood-Brain Barrier; Catalysis; Cell Line, Tumor; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Palladium; Sesquiterpenes; Structure-Activity Relationship | 2021 |
Development of a safe and scalable route towards a tau PET tracer precursor.
Topics: Alzheimer Disease; Amination; Carbazoles; Catalysis; Humans; Palladium; Positron-Emission Tomography; tau Proteins | 2018 |
Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain Chemistry; Calcium Signaling; Catalysis; Cell Line; Delayed-Action Preparations; Drug Evaluation, Preclinical; Female; Hydrogen; Male; Maze Learning; Membrane Potential, Mitochondrial; Mice; Mice, 129 Strain; Mitochondria; Nanoparticles; Oxidative Stress; Oxygen Consumption; Palladium; Protein Aggregation, Pathological | 2019 |
Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Autophagy; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Gold; Humans; Metal Nanoparticles; Palladium; Particle Size; Quercetin; Structure-Activity Relationship; Surface Properties | 2019 |
Access to 2-(Het)aryl and 2-Styryl Benzoxazoles via Palladium-Catalyzed Aminocarbonylation of Aryl and Vinyl Bromides.
Topics: Alzheimer Disease; Aminophenols; Benzoxazoles; Carbon Monoxide; Catalysis; Hydrocarbons, Brominated; Molecular Structure; Palladium; Peroxisome Proliferator-Activated Receptors; Styrenes; Vinyl Compounds | 2015 |
Oxidative biaryl coupling of thiophenes and thiazoles with arylboronic acids through palladium catalysis: otherwise difficult C4-selective C-H arylation enabled by boronic acids.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Boronic Acids; Carbon; Catalysis; Cyclic N-Oxides; Humans; Hydrogen; Oxidation-Reduction; Palladium; Protease Inhibitors; Stereoisomerism; Thiazoles; Thiophenes | 2011 |
Synthesis of 4,5-dianilinophthalimide and related analogues for potential treatment of Alzheimer's disease via palladium-catalyzed amination.
Topics: Alzheimer Disease; Amination; Catalysis; Palladium; Phthalimides | 2005 |